Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses

Area of Science:

• Immunology
• Virology
• Public Health

Background:

• Respiratory viruses (e.g., influenza, SARS-CoV-2, RSV) cause significant global morbidity and mortality.
• Current vaccines often fail to induce durable protective immunity against these rapidly replicating mucosal pathogens.
• Existing vaccines have limitations in controlling widespread respiratory viral infections effectively.

Purpose of the Study:

• To review the challenges hindering the development of effective mucosal respiratory vaccines.
• To explore strategies for creating next-generation vaccines against respiratory viruses.
• To discuss factors influencing vaccine efficacy and public health policy.

Main Methods:

• Literature review of challenges in respiratory mucosal vaccine development.
• Analysis of viral replication kinetics and immune response timing.
• Discussion of vaccine design parameters and public health policy implications.

Main Results:

• Rapid replication of respiratory viruses in the epithelium precedes adaptive immune responses.
• Existing vaccines struggle to confer complete and durable protection against these viruses.
• Vaccine antigen design, delivery route, and timing are critical factors.

Conclusions:

• Overcoming rapid viral replication and immune evasion is key for effective respiratory vaccines.
• Next-generation vaccines require novel strategies considering antigen configuration, adjuvants, and delivery methods.
• Optimized vaccination policies are essential for controlling respiratory viral diseases.